Haemonetics Corporation (HAE) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 45.50M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 45.50M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 45.50M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 45.50M | (m) | (m) |
| 2026-03-31 | 45.45M | (m) | (m) |
| 2025-12-31 | 46.47M | (m) | (m) |
| 2025-09-30 | 46.81M | (m) | (m) |
| 2025-06-30 | 48.18M | (m) | (m) |
| 2024-12-31 | 50.24M | (m) | (m) |
| 2024-09-30 | 50.22M | (m) | (m) |
| 2024-06-30 | 51.18M | (m) | (m) |
| 2024-03-31 | 50.84M | (m) | (m) |
| 2023-12-31 | 50.79M | (m) | (m) |
| 2023-09-30 | 50.74M | (m) | (m) |
| 2023-06-30 | 50.71M | (m) | (m) |
| 2022-12-31 | 50.45M | (m) | (m) |
| 2022-09-30 | 50.61M | (m) | (m) |
| 2022-06-30 | 51.32M | (m) | (m) |
| 2021-12-31 | 51.11M | (m) | (m) |
| 2021-09-30 | 51.11M | (m) | (m) |
| 2021-06-30 | 51.03M | (m) | (m) |
| 2020-12-31 | 50.82M | (m) | (m) |
| 2020-09-30 | 50.78M | (m) | (m) |
| 2020-06-30 | 50.70M | (m) | (m) |
| 2019-12-31 | 50.30M | (m) | (m) |
| 2019-09-30 | 50.68M | (m) | (m) |
| 2019-06-30 | 50.77M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |